Join iREIT on Alpha today to get the most in-depth research that includes REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, and other income alternatives. 438 testimonials and most are 5 stars. Nothing to lose with our FREE 2-week trial .The reason behind that is the fact that I consider this one of the mostI just broke a new personal record, which is how much time it took me to write this article.Leo Nelissen is an analyst focusing on major economic developments related to supply chains, infrastructure, and com ...

Join iREIT on Alpha today to get the most in-depth research that includes REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, and other income alternatives. 438 testimonials, and most are 5 stars. Nothing to lose with our FREE 2-week trial .More than a year ago, I wrote an article titled "The One Chart That Keeps Me Up At Night." The article was about the ( updated ) chart below, which displays the long-term purchasing powerLeo Nelissen is an analyst focusing on major economic developments related to supply chains ...

文章核心观点 - 特朗普欲对进口药品加征关税，这将给制药行业带来重大变化，且行业对关税风险认识不足 [1][2][5] 分组1：关税提议情况 - 特朗普2月中旬首次提出对进口药品加征最高25%关税，之后多次提及并暗示4月初公布细节，目前不确定周三是否会有相关进展 [2] 分组2：行业现状 - 长期贸易协定使制药行业免受关税影响，1994年世贸组织协定取消了大量药品及原料关税，促使公司采取降低税率的商业策略 [1][3] - 因部分国家税率低，公司在当地开展制造业务并将知识产权注册在此，整体纳税降低，爱尔兰是主要受益者 [4] 分组3：风险评估 - Leerink Partners分析师警告行业对关税风险认识不足，企业虽可调整策略减轻负面影响，但因全球税收策略和供应链复杂及关税持久性不确定，调整需时间 [5] - 伯恩斯坦分析师基于多方面数据评估，认为默克、艾伯维、安进、辉瑞面临最高风险，礼来、吉利德、百时美施贵宝和莫德纳风险适中 [6]